|
ATP5F1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.97189997453285E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.57899999975575E-07 |
| Normal-vs-Stage2 |
1.185970E-02 |
| Normal-vs-Stage3 |
1.819600E-04 |
| Normal-vs-Stage4 |
2.186900E-04 |
| Stage1-vs-Stage2 |
9.691200E-01 |
| Stage1-vs-Stage3 |
2.415400E-01 |
| Stage1-vs-Stage4 |
6.360000E-01 |
| Stage2-vs-Stage3 |
3.919400E-01 |
| Stage2-vs-Stage4 |
6.439400E-01 |
| Stage3-vs-Stage4 |
7.802000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.64070004646544E-09 |
| Normal-vs-AfricanAmerican |
1.058950E-03 |
| Normal-vs-Asian |
2.361600E-01 |
| Caucasian-vs-AfricanAmerican |
2.511800E-01 |
| Caucasian-vs-Asian |
9.732600E-01 |
| AfricanAmerican-vs-Asian |
7.103800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.09229997164095E-09 |
| Normal-vs-Female |
8.34230000000824E-05 |
| Male-vs-Female |
3.491800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.48639999994782E-06 |
| Normal-vs-Extreme_Weight |
4.02039999958248E-07 |
| Normal-vs-Obese |
1.89340000000815E-06 |
| Normal-vs-Extreme_Obese |
9.955200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.267000E-01 |
| Normal_Weight-vs-Obese |
7.774600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.031800E-01 |
| Extreme_Weight-vs-Obese |
8.445400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.476000E-01 |
| Obese-vs-Extreme_Obese |
2.321000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.236800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.69969999688868E-08 |
| Normal-vs-Age(61-80Yrs) |
6.85289999968752E-07 |
| Normal-vs-Age(81-100Yrs) |
1.560320E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.990600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.277400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.887400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.277400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.506600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.715800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.99909999244153E-09 |
| Normal-VS-Type2 PRCC |
8.012600E-04 |
| Normal-VS-KIRP CIMP |
5.02390018475296E-10 |
| Normal-VS-Unclassified PRCC |
1.018170E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.828200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.761300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.767800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.323300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.226800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.939900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.80009999999742E-05 |
| Normal-vs-N1 |
2.23969999990636E-07 |
| Normal-vs-N2 |
1.354570E-01 |
| N0-vs-N1 |
6.662000E-02 |
| N0-vs-N2 |
4.090400E-01 |
| N1-vs-N2 |
9.999000E-01 |
|
|
